Filter: All | Regulatory
RegulatoryCorrection: Market clearance for CellaVision DC-1 in the US and good profitability in the quarter
RegulatoryMarket clearance for CellaVision DC-1 in the US and good profitability in the quarter
RegulatoryThe Nomination Committee of CellaVision AB announces that the Chairman of the Board, Sören Mellstig, has declined re-election at the 2021 Annual General Meeting
RegulatoryCellaVision AB: Good profitability despite negative COVID-19-effect
RegulatoryCellaVision AB: Zlatko Rihter leaves his position as CEO at CellaVision AB
RegulatoryCellaVision AB: CellaVisions Annual report for 2019 is now available
RegulatoryCellaVision AB: Notice of the Annual General Meeting 2020
RegulatoryCellaVision AB: Stable start of the year with good growth in APAC
RegulatoryCellaVision AB presents the first quarter for 2020 on April 22, at 11:00 CET
RegulatoryCellaVision AB: The Annual General Meeting of CellaVision AB (publ) is postponed and the Board of Directors has decided to withdraw the proposed dividend due to the coronavirus, Covid-19
RegulatoryCellaVision AB: Notice of 2020 Annual General Meeting of CellaVision (publ)
RegulatoryCellaVision AB: Year-end bulletin, Jan-Dec 2019
RegulatoryCellaVision AB presents the year-end bulletin for 2019 on February 5 at 11:00 CET
RegulatoryCellaVision AB: Continued growth and acquisition of RAL Diagnostics
RegulatoryCellaVision AB presents the third quarter for 2019 on October 23 at 11:00 CET
RegulatoryCellaVision completes the acquisition of RAL Diagnostics
RegulatoryCellaVision AB to acquire RAL Diagnostics
RegulatoryCellaVision ABs strongest quarter ever with continued growth
RegulatoryCellaVision AB presents the second quarter for 2019 on July 16 at 11:00 CET
RegulatoryCellaVision AB: Bulletin from AGM held on May 8, 2019
RegulatoryCellaVision AB: Interim report January-March 2019
RegulatoryCellaVision AB: CellaVisions Annual report for 2018 is now available
RegulatoryCellaVision AB: Notice of 2019 Annual General Meeting of CellaVision (publ)
RegulatoryCellaVision AB Year-end bulletin, Jan-Dec 2018
RegulatoryCellaVision AB launches new product, CellaVision® DC-1, for small and mid-sized hematology laboratories
RegulatoryCellaVision AB: Interim report January-September 2018
RegulatoryCellaVision AB: Interim Report January-June 2018
RegulatoryCellaVision AB: Bulletin from AGM held on May 4, 2018
RegulatoryCellaVision AB: Interim report January-March 2018
RegulatoryCellaVision AB: CellaVision's 2017 Annual report now available
Older releases »

Subscribe to updates


Information request

Are you looking for some particular information about our company or our business?

Click here to get in touch


Analysts

ABG Sundal Collier AB
Victor Forssell
victor.forssell@abgsc.se
+46 8 566 286 92

Rickard Anderkrans
rickard.anderkrans@abgsc.se
+46 8 566 286 73

Berenberg
Carl-Oscar Bredengen
oscar.bredengen@berenberg.com
+44 20 3753 3160

Gerhard Orgonas
gerhard.orgonas@brerenberg.com
+44 20 3465 2635

Carnegie
Ulrik Trattner
ulrik.trattner@carnegie
+46 8 5886 8589

Kristofer Liljeberg
kristofer.liljeberg@carnegie.se
+46 8 5886 87 63

Pareto Securities AB
Christian Lee
christian.lee@paretosec.com
+46 84 02 52 67

Peter Östling
peter.ostling@paretosec.com
+46 8 402 52 68

Redeye
Erik Nordström
erik.nordstrom@redeye.se

Arvid Necander
arvid.necander@redeye.se

 

Access our Student Resources

To access this resource, please provide the following information about yourself.